Clinical and immunological aspects of envenomations by Bothrops snakes

Journal of Venomous Animals and Toxins Including Tropical Diseases

Volumn 17, Issue 2, 2011, Pages 130-141

  Luna, K P O ^a,b   da Silva, M B ^b   Pereira, V R A ^c  

^a University of Paraíba   (Brazil)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Clinical aspects; Envenomations; Immunology; Snakes

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C5A; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; SNAKE VENOM; SNAKE VENOM ANTISERUM; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLINICAL FEATURE; COMPLEMENT SYSTEM; CYTOKINE PRODUCTION; ENVENOMATION; HUMAN; NONHUMAN; PATIENT ASSESSMENT; POISONOUS SNAKE; PROTEIN EXPRESSION; SNAKEBITE; TOXIN ANALYSIS;

BOTHROPS; SERPENTES;

EID: 79958103401     PISSN: 16789199     EISSN: 16789199     Source Type: Journal    
DOI: 10.1590/s1678-91992011000200003     Document Type: Article

References (77)

1. Kasturiratne A, Wickremasinghe AR, de Silva N, Gunawardena, NK, Pathmeswaran, A et al. The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths. PLoS Med. 2008;5(11):218.
2. World Health Organization (WHO) [homepage on the Internet]. Neglected tropical diseases [cited January 2011]. Available from: http://www.who.int/neglected_diseases/diseases/snakebites/en/index.html.
3. Williams D, Gutiérrez JM, Harrison R, Warrell DA, White J, Winkel K, Gopalakrishnakone, P. The Global Snake Bite Initiative: an antidote for snake bite. Lancet. 2010; 375(9708):89-91.
4. Gutiérrez JM, Williams D, Fan H, Warrell DA. Snakebite envenoming from a global perspective: towards an integrated approach. Toxicon. 2010; 56(7):1223-35.
5. Gutiérrez, JM, Sanz, L, Flores-Díaz, M, Figueroa, L, Madrigal, M, et al. Impact of regional variation in Bothrops asper snake venom on the design of antivenoms: integrating antivenomics and neutralization approaches. J Proteome Res. 2010; 9(11):564-77.
6. Bochner RS, Struchiner CJ. Epidemiologia dos acidentes ofídicos nos últimos 100 anos no Brasil: uma revisão. Cad Saúde Pública. 2003; 19(1):7-16.
7. Petricevich VL, Teixeira CFP, Tambourghi DV, Gutiérrez JM. Increments in serum cytokine and nitric oxide levels in mice injected with Bothrops asper and Bothrops jararaca snake venom. Toxicon. 2000; 38 1253-66.
8. Meki ARMA, El-Dean ZMM. Serum interleukin-1β, interleukin-6, nitric oxide and α1-antitripsin in scorpion envenomed children. Toxicon. 1998; 36(12):1851-9.
9. Tambourgi DV, dos Santos MC, Furtado M de F, de Freitas MC, da-Silva DW, Kipnis TL. Pro-inflammatory activities in elapid snake venoms. Br J Pharmacol. 1994;112(3):723-7.
10. Radi RBJS, Beckman JS, Bush KM, Freeman BA. Peroxynitriteoxidation of sulphydryls: the cytotoxic potential of superoxide and nitric oxide. J Biol Chem. 1991;266:4244-50.
11. Hogg N, Darley-Usmar VM, Wilson MT, Moncada S. Production of hydroxyl radicals from the simultaneous generation of superoxide and nitric oxide. Biochem J. 1992;281:419-24.
12. Farsky SH, Walber J, Costa-Cruz M, Cury Y, Teixeira CF. Leukocyte response induced by Bothrops jararaca crude venom: in vivo and in vitro studies. Toxicon. 1997;35(2):185-93.
13. Dias-Da-Silva W, Tambourgi DV, Campos ACMR, Magnoli F, Petricevich VL, Kipnis TL. Complement activation by animal venoms. J Toxicol Toxin Rev. 1995;14(3):375-400.
14. Koh DCI, Armugam A, Jeyaseelan K. Snake venom components and their application in biomedicine. Cell Mol Life Sci. 2006;63(24):3030-41.
15. White J. Snake venoms and coagulopathy. Toxicon. 2005;45(8):951-67.
16. Kamiguti AS, Cardoso JLC, Theakston RDG, Sano-Martins IS, Hutton RA, Rugman FP, et al. Coagulopathy and hemorrhage in human victims of Bothrops jararaca envenoming in Brazil. Toxicon. 1991;29(8): 961-72.
17. Mandelbaum FR. Isolamento e caracterização de dois fatores hemorrágicos do veneno de Bothrops jararaca [thesis]. São Paulo: Escola Paulista de Medicina;1976.
18. Gutiérrez JM, Bolaños R Arroyo O. Mionecrosis, hemorragia y edema inducidos por el veneno de Bothrops asper en ratón blanco. Toxicon. 1980;18(5-6):603-10.
19. Gutiérrez JM, Romero M, Díaz C, Borkow G, Ovadia M. Isolation and characterization of a metalloproteinase with weak hemorrhagic activity from the venom of the snake Bothrops asper (terciopelo). Toxicon. 1995;33(1)19-29.
20. Rucavado NA, Núñez J, Gutiérrez JM. Blister formation and skin damage induced by BaP1, a hemorrhagic metalloproteinase from the venom of the snake Bothrops asper. Int J Exp Pathol. 1998;79(4):245-56.
21. Rucavado A, Flores-Sánchez E, Franceschi A, Magalhães A, Gutiérrez JM. Characterization of the local tissue damage induced by LHF-II, a metalloproteinase with weak hemorrhagic activity isolated from Lachesis muta muta snake venom. Toxicon. 1999;37(9):1297-312.
22. Gonçalves LR, Mariano M. Local hemorrhage induced by Bothrops jararaca venom: relationship to neurogenic inflammation. Med Inflamm. 2000;9(2):101-7
23. Meier J, White J. Handbook of clinical toxicology of animal venoms and poisons. Boca Raton: CRC Press; 1995.
24. Ojnuckarin P, Mahasandana S, Intragumthornchai T, Sutcharitchan P, Swasdikul D. Prognostic factors of green pit viper bites. Am J Trop Med Hyg. 1998, 58(1):22-5.
25. Tallon RW, Koch KL, Barnes SG, Ballard JO. Envenomation coagulopathy from snake bites. N Engl J Med. 1981;305(2):1347-8.
26. Sano-Martins IS, Santoro ML, Castro SC, Fan HW, Cardoso JL, Theakston RDG. Platelet aggregation in patients bitten by the Brazilian snake Bothrops jararaca. Thromb Res. 1997;87(2):183-9527.
27. Santoro ML, Sano-Martins IS. Platelet dysfunction during Bothrops jararaca snake envenomation in rabbits. Thromb Haemost. 2004;92 (2):369-83.
28. Santoro ML, Sano-Martins IS, Chamone DA. In vivo platelet activation induced by Bothrops jararaca venom in rabbits. Platelets. 1994;5(3):162-70.
29. Maruyama M, Kamiguti AS, Cardoso JL, Sano-Martins IS, Chudzinski AM, Santoro ML, et al. Studies on blood coagulation and fibrinolysis in patients bitten by Bothrops jararaca (jararaca). Thromb Haemost. 1990;63(3):449-53.
30. Santoro ML, Sano-Martins IS, Fan HW, Cardoso JL, Theakston RDG, Warrell DA, et al. Haematological evaluation of patients bitten by the jararaca, Bothrops jararaca, in Brazil. Toxicon. 2008;51(8):1440-8.
31. Asano S, Okano A, Ozawa K, Nakahata T, Ishibashi T, Koike K, et al. In vivo effects of recombinant human interleukin-6 in primates: stimulated production of platelets. Blood. 1990;75(8):1602-5.
32. Hill RJ, Warren MK, Levin J. Stimulation of thrombopoiesis in mice by human recombinant interleukin 6. J Clin Invest. 1990,85(4):1242-7.
33. Ishibashi T, Kimura H, Shikama Y, Uchida T, Kariyone S, Hirano T, et al. Interleukin-6 is a potent thrombopoietic factor in vivo in mice. Blood. 1989;74(4):1241-4.
34. Avila-Aguero ML, Paris MM, Hu S, Peterson PK, Gutiérrez JM, Lomonte B, et al. Systemic cytokine response in children bitten by snakes in Costa Rica. Pediatr Emerg Care. 2001;17(6):425-9.
35. Barraviera B, Lomonte B, Tarkowski A, Hanson LA, Meira DA. Acute-phase reactions including cytokines in patients bitten by Bothrops and Crotalus snakes in Brazil. J Venom Anim Toxins. 1995;1(1):11-22.
36. Lomonte B, Tarkowski A, Hanson LA. Host response to Bothrops asper snake venom. Analysis of edema formation, inflammatory cells, and cytokine release in a mouse model. Inflammation. 1993;17(2):93-105.
37. Smith MJ, Bolam JP. Anti-inflammatory effects of blood platelets in the rat. J Patol. 1979;129(2):65-71.
38. Weyrich AS, Lindemann S, Zimmerman GA. The evolving role of platelets in inflammation. J Thromb Haemost. 2003;1(9):1897-905.
39. Thomas L, Chausson N, Uzan J, Kaidomar S, Vignes R, Plumelle Y, et al. Thrombotic stroke following snake bites by the "Fer-de-Lance" Bothrops lanceolatus in Martinique despite antivenom treatment: a report of three recent cases. Toxicon. 2006;48(1):23-8.
40. Malbranque S, Piercecchi-Marti MD, Thomas L, Barbey C, Courcier D, Bucher B, et al. Fatal diffuse thrombotic microangiopathy after a bite by the "Fer-de-Lance" pit viper (Bothrops lanceolatus) of Martinique. Am J Trop Med Hyg. 2008;78(6):856-61.
41. Numeric P, Moravie V, Didier M, Chatot-Henry D, Cirille S, Bucher B, et al. Multiple cerebral infarctions following a snakebite by Bothrops caribbaeus. Am J Trop Med Hyg. 2002;67(3):287-8.
42. Wuster W, Golay P, Warrel D. Synopsis of recent developments in venomous snake systematic, No. 3. Toxicon.1999;37(8):1123-9.
43. Gutiérrez JM, Chaves F, Gene JA, Lomonte B, Camacho Z, Schosinsky K. Myonecrosis induced in mice by a basic myotoxin isolated from the venom of the snake Bothrops nummifer (jumping viper) from Costa Rica. Toxicon. 1989;27(7):735-45
44. Brunton LL, Lazo JS, Parker KL, editors. Goodman & Gilman: as bases farmacológicas da terapêutica. 9th ed. Rio de Janeiro: Mc Graw-Hill; 1996.
45. Moura-da-Silva AM, Desmond H, Laing G, Theakston RDG. Isolation and comparison of myotoxins isolated from venoms of different species of Bothrops snakes. Toxicon. 1991;29(6):713-23.
46. França FOS, Málaque CMS. Acidente botrópico. In: Cardoso JLC, França FOS, Wen FH, Málaque CMS, Haddad Jr. V, editors. Animais peçonhentos no Brasil: biologia, clínica e terapêutica dos acidentes. São Paulo: Sarvier/FAPESP; 2003.
47. Rocha e Silva M, Beraldo, WT, Rosenfeld G. Bradykinin, a hypotensive and smooth muscle stimulating factor released from plasma globulin by snake venoms and by trypsin. 1949. Am J Physiol. 1949;156(2):261-73.
48. Barros SF, Friedlanskaia I, Petricevich VL, Kpinis TL. Local inflammation, lethality and cytokine release in mice injected with Bothrops atrox venom. Mediators Inflamm. 1998;7(5):339-46.
49. Clissa PB, Lopes-Ferreira M, Della-Casa MS, Farsky SH, Moura-Da-Silva AM. Importance of jararhagin disintegrin-like and cysteine-rich domains in the early events of local inflammatory response. Toxicon. 2006;47(5):591-6.
50. Xavier Da Silva V, Rodrigues MT. Taxonomic revision of the Bothrops neuwiedi complex (Serpentes, Viperidae) with description of a new species. Phyllomedusa. 2008;7(1):45-90.
51. Lopes DS, Baldo C, Oliveira C de F, Alcântara TM, Oliveira JDD, Goulart LR. Characterization of inflammatory reaction induced by neuwiedase, a P-I metalloproteinase isolated from Bothrops neuwiedi venom. Toxicon. 2009;54(1):42-9.
52. Fernandes CM, Zamuner SR, Zuliani PJ, Rucavado A, Gutiérrez JM, Teixeira CF. Inflammatory effects of BaP1 a metalloproteinase isolated from Bothrops asper snake venom: leukocyte recruitment and release of cytokines. Toxicon. 2006;47(5)549-59.
53. Costa EP, Clissa PB, Teixeira CF, Moura-Da-Silva AM. Importance of metalloproteinases and macrophages in viper snake envenomation-induced local inflammation. Inflammation. 2002;26(1):13-7.
54. Stylianou E, Saklatvala J. Molecules in focus: interleukin-1. Int J Biochem Cell Biol. 1998;30 (1):1075-9.
55. Ebnet K, Vestweber D. Molecular mechanisms that control leukocytes extravasation: the selectins and the chemokines. Histochem Cell Biol. 1999;112(1):1-23.
56. Hopkins SJ. The pathophisiological role of cytokines. Leg Med. 2003;5(1):S45-S57
57. Clissa PB, Laing GD, Theakston RD, Mota I, Taylor MJ, Moura-da-Silva AM. The effect of jararhagin, a metalloproteinase from Bothrops jararaca venom, on pro-inflammatory cytokines released by murine peritoneal adherent cells. Toxicon. 2001;39(10):1567-73.
58. Clissa PB, Lopes-Ferreira M, Della-Casa MS, Farsky SH, Moura-da-Silva AM. Importance of jararhagin disintegrin-like and cysteine-rich domains in the early events of local inflammatory response. Toxicon. 2006;47(5):591-6.
59. Luna KPO, Melo CML, Pascoal VPM, Martins-Filho AO, Pereira VRA. Bothrops erythromelas snake venom induces a proinflammatory response in mice splenocytes. Int J Interf Cytok Mediator Res. 2011;2011(3):9-18.
60. Mossman TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 1989;7:145-73
61. Farsky SH, Gonçalves LR, Gutiérrez JM, Correa AP, Rucavado A, Gasque P, et al. Bothrops asper snake venom and its metalloproteinase BaP1 activate the complement system. Mediators Inflamm. 2000;9(5):213-21.
62. Luna KP, Xavier EM, Pascoal VP, Martins-Filho AO, Pereira VR. Humoral immune response of patients bitten by the snake Bothrops erythromelas. Rev Soc Bras Med Trop. 2010;43(6):731-2.
63. Rodrigues FGP, Kanashiro MM, Petrestki JH, Lemos L, da Silva WD, Kipnis TL. The complement system is involved in acute inflammation but not in the hemorrhage produced by a Bothrops atrox snake venom low molecular mass proteinase. Mol Immunol. 2004;40(16):1149-56.
64. Hawgood BJ. Pioneers of anti-venomous serotherapy: Dr Vital Brazil (1865-1950). Toxicon.1992;30(5-6):573-9.
65. Hawgood BJ. Doctor Albert Calmette 1863-1933: founder of antivenomous serotherapy and of antituberculous BCG vaccination. Toxicon. 1999;37(9):1241-58
66. Brazil V. Contribuição ao estudo do veneno ofídico: tratamento das mordeduras de cobra. Rev Med São Paulo. 1903;(13):265-78
67. Brazil V. Contribution à l'étude de l'intoxication d'origine ophidienne. Paris: Maloine, 1904.
68. Cardoso DFP. Produção de soro antitoxinas e perspectivas de modernização por técnicas de biologia molecular. In: Cardoso JLC, França FOS, Wen FH, Málaque CMS, Haddad Jr. V, editors. Animais peçonhentos no Brasil: biologia, clínica e terapêutica dos acidentes. São Paulo: Sarvier/FAPESP; 2003.
69. Warrell DA. Geographical intraspecies variation in the clinical manifestation of envenoming by snakes. In: Thorpe RS, Wuster W, Malhorta A, editors. Venomous snakes: ecology, evolution and snake bites. Oxford: Claredon Press; 1997. p. 189-203.
70. Gutiérrez JM, Lomonte B, León G, Alape-Girón A, Flores-Díaz M, Sanz L, et al. Snake venomics and antivenomics: proteomic tools in the design and control of antivenoms for the treatment of snakebite envenoming. J Proteomics. 2009; 72 (2):165-82.
71. Calvete JJ, Sanz L, Angulo Y, Lomonte B, Gutiérrez JM. Venoms, venomics, antivenomics. FEBS Lett. 2009;583(11):1736-43.
72. Alape-Girón A, Sanz L, Escolano J, Flores-Díaz M, Madrigal M, Sasa M, et al. Snake venomics of the lancehead pitviper Bothrops asper: geographic, individual, and ontogenetic variations. J Proteome Res. 2008;7(8):3556-71.
73. Nuñez V, Cid P, Lomonte B, Gutiérrez JM, Calvete JJ, et al. Snake venomics and antivenomics of Bothrops atrox venoms from Colombia and the Amazon regions of Brazil, Peru and Ecuador suggest the occurrence of geographic variation of venom phenotype by a trend towards paedomorphism. J Proteomics. 2009;73(1):57-78.
74. Gutiérrez JM, Sanz L, Flores-Días M, Figueroa L, Madrigal M, Herrera M et al. Impact of regional variation in Bothrops asper snake venom on the design of antivenoms: integrating antivenomics and neutralization approaches. J Proteomes Res. 2010;9(1):564-77.
75. Arce-Estrada V, Azofeifa-Cordero G, Estrada R, Alape-Girón A, Flores-Díaz M. Neutralization of venom-induced hemorrhage by equine antibodies raised by immunization with a plasmid encoding a novel P-II metalloproteinase from the lancehead pitviper Bothrops asper. Vaccine. 2009;27(3):460-6.
76. Azofeifa-Cordero G, Arce-Estrada V, Flores-Díaz M, Alape-Girón A. Immunization with cDNA of a novel P-III type metalloproteinase from the rattlesnake Crotalus durissus durissus elicits antibodies which neutralize 69% of the hemorrhage induced by the whole venom. Toxicon. 2008;52(2):302-8.
77. Wagstaff SC, Laing GD, Theakston RD, Papaspyridis C, Harrison RA, et al. Bioinformatics and multiepitope DNA immunization to design rational snake antivenom. PLoS Med. 2006;3(6):e184.